International audiencePURPOSE: Interim 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) has shown to be an accurate predictor of prognosis in Hodgkin's lymphoma (HL). However, FDG PET response criteria are a matter of ongoing debate. The aim of this study was to confirm the prognostic value of interim PET/CT in HL patients treated with an interim response-adapted strategy and to compare the respective performances of different published criteria. METHODS: Newly diagnosed patients with HL underwent interim PET/CT after four courses of Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). The treatment strategy was adapted according to prognostic factors at diagnosis and interim PET/CT and CT results. PET images w...
Our objective was to assess the prognostic value of (18)F-FDG PET after 2 cycles of chemotherapy usi...
Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...
PURPOSE: The use of early (interim) PET restaging during first-line therapy of Hodgkin's lymphom...
International audiencePURPOSE: Interim 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomograph...
Given the excellent survival rates for early-stage Hodgkin lymphoma (HL), the young age of many pati...
This study aimed to systematically review and meta-analyse the value of interim (18) F-fluoro-2-deox...
none17siThis retrospective study included 246 patients with a new diagnosis of Hodgkin Lymphoma (HL)...
PURPOSE: Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) were...
Hodgkin lymphoma, even in advanced-stage, is a highly curable malignancy, but treatment is associate...
The HD18 study for patients with newly diagnosed advanced-stage Hodgkin lymphoma (HL) used positron ...
International audience: PET performed after 2 cycles of chemotherapy (PET2) allows prediction of out...
PURPOSE: Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) we...
A retrospective, international, multicenter study was undertaken to assess: (i) the prognostic role ...
The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients wit...
Our objective was to assess the prognostic value of (18)F-FDG PET after 2 cycles of chemotherapy usi...
Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...
PURPOSE: The use of early (interim) PET restaging during first-line therapy of Hodgkin's lymphom...
International audiencePURPOSE: Interim 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomograph...
Given the excellent survival rates for early-stage Hodgkin lymphoma (HL), the young age of many pati...
This study aimed to systematically review and meta-analyse the value of interim (18) F-fluoro-2-deox...
none17siThis retrospective study included 246 patients with a new diagnosis of Hodgkin Lymphoma (HL)...
PURPOSE: Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) were...
Hodgkin lymphoma, even in advanced-stage, is a highly curable malignancy, but treatment is associate...
The HD18 study for patients with newly diagnosed advanced-stage Hodgkin lymphoma (HL) used positron ...
International audience: PET performed after 2 cycles of chemotherapy (PET2) allows prediction of out...
PURPOSE: Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) we...
A retrospective, international, multicenter study was undertaken to assess: (i) the prognostic role ...
The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients wit...
Our objective was to assess the prognostic value of (18)F-FDG PET after 2 cycles of chemotherapy usi...
Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...
PURPOSE: The use of early (interim) PET restaging during first-line therapy of Hodgkin's lymphom...